USA: Manhattan residents express hope following BioNTech/Pfizer COVID vaccine trial

Pharmaceutical companies Pifzer and BioNTech announced that they have jointly produced a vaccine that has proven to be 90 percent effective against coronavirus, following a successful trial. Manhattan residents could be seen embracing the news on Monday. "Everyone hopes for the best. But the main thing though is that, of course, there is still time before it will be mass produced,” said Zack, a passer-by. "While it's definitely a fate of hope, we obviously should not give up. We have to be careful, we still have to do proper face mask and social distancing. But is definitely very positive to hear that we're actually making progress on a vaccine," he concluded. "I just hope that we all can get it and we are on the way to normal life," said a Pfizer worker, Betty Ann. The two pharmaceutical companies said they are planning to produce up to 50 million vaccine doses in 2020 and up to one point three billion doses in 2021, pending extensive research and approval by the US Food and Drug Administration (FDA).

Самое интересное

Новости партнеров

ТемыВсе темы